Skip to main content

Kronos Bio backer’s VC firm raises $600M for life science investments

Weeks after raising one of the industry’s largest Series A rounds of the year, biotech veteran-turned-real estate developer Arie Belldegrun’s venture capital firm has closed a $600 million round for new life sciences investments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.